Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overview of pharmacogenetics.
Katz DA, Bhathena A. Katz DA, et al. Curr Protoc Hum Genet. 2009 Jan;Chapter 9:Unit 9.19. doi: 10.1002/0471142905.hg0919s60. Curr Protoc Hum Genet. 2009. PMID: 19170034 Review.
CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
Katz DA, Grimm DR, Cassar SC, Gentile MC, Ye X, Rieser MJ, Gordon EF, Polzin JE, Gustavson LE, Driscoll RM, O'dea RF, Williams LA, Bukofzer S. Katz DA, et al. Clin Pharmacol Ther. 2004 Jun;75(6):516-28. doi: 10.1016/j.clpt.2004.01.013. Clin Pharmacol Ther. 2004. PMID: 15179406 Clinical Trial.
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.
Innocenti F, Ramírez J, Obel J, Xiong J, Mirkov S, Chiu YL, Katz DA, Carr RA, Zhang W, Das S, Adjei A, Moyer AM, Chen PX, Krivoshik A, Medina D, Gordon GB, Ratain MJ, Sahelijo L, Weinshilboum RM, Fleming GF, Bhathena A. Innocenti F, et al. Among authors: katz da. Pharmacogenet Genomics. 2013 Jul;23(7):374-81. doi: 10.1097/FPC.0b013e3283623e81. Pharmacogenet Genomics. 2013. PMID: 23670235 Free PMC article. Clinical Trial.
333 results